本页面由Tiger Trade Technology Pte. Ltd.提供服务

Revolution Medicines, Inc.

193.95
+4.192.21%
盘后:193.950.00000.00%19:35 EDT
成交量:166.74万
成交额:3.20亿
市值:415.71亿
市盈率:-21.74
高:194.26
开:187.79
低:184.76
收:189.76
52周最高:224.31
52周最低:47.28
股本:2.14亿
流通股本:1.85亿
量比:0.74
换手率:0.90%
股息:- -
股息率:- -
每股收益(TTM):-8.9212
每股收益(LYR):-5.9502
净资产收益率:-79.09%
总资产收益率:-30.12%
市净率:15.95
市盈率(LYR):-32.60

数据加载中...

2026/05/07

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/05/07

重要事件披露

Form 8-K - Current report
2026/04/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/17

重要事件披露

Form 8-K - Current report
2026/04/16

重要事件披露

Form 8-K - Current report
2026/04/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/15

[补充]招股说明书

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
2026/04/13

重要事件披露

Form 8-K - Current report
2026/03/26

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities